Giulia Candini
Bologna, 40126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult Cdkl5 KO Mice.
Journal: International journal of molecular sciences
Published: February 11, 2026
A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoids.
Journal: Frontiers in bioengineering and biotechnology
Published: November 12, 2025
Adult-Onset Deletion of CDKL5 in Forebrain Glutamatergic Neurons Impairs Synaptic Integrity and Behavior in Mice.
Journal: International journal of molecular sciences
Published: June 16, 2025
Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiency.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: May 30, 2025
Lactic acid bacteria as microbial cell factories for the in vivo delivery of therapeutic proteins as secretable TAT fusion products.
Journal: Journal of biological engineering
Published: March 27, 2025
Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder.
Journal: International journal of molecular sciences
Published: February 14, 2025
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder.
Journal: Journal of neurodevelopmental disorders
Published: January 24, 2024
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder.
Journal: Neurobiology of disease
Published: March 09, 2023
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder.
Journal: International journal of molecular sciences
Published: February 08, 2023
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: August 27, 2022
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder.
Journal: International journal of molecular sciences
Published: July 04, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026